{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:10:00Z","timestamp":1788898200226,"version":"build-2803163510"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neoadjuvant therapy (NAT) has become central to the management of borderline resectable pancreatic ductal adenocarcinoma (BRPC). This surgical narrative review offers a contemporary synthesis of evidence and guidelines, with emphasis on pretreatment staging, post-NAT surgical selection, intraoperative vascular tactics, and postoperative care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a structured narrative review of randomized and prospective studies, high-quality observational cohorts, and major international guidelines published through 31 December 2025. A systematic search of PubMed was performed, and key data were synthesized to inform a practical decision-making framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Although BRPC remains defined largely by vascular anatomy, biological and conditional factors are increasingly incorporated into decision-making. NAT is preferred initially, with resection reserved for carefully selected responders. For post-NAT restaging, contrast-enhanced CT and CA19-9 kinetics are the mainstays, while FDG-PET, DWI-MRI, radiomics, and biomarkers serve as problem-solving adjuncts when findings are equivocal. Surgical exploration is guided by physiologic recovery, absence of metastatic progression, and multidisciplinary consensus. Staging laparoscopy remains useful for detecting occult metastases. Intraoperative vascular resection is margin-driven, not routine: venous resection is standard, arterial resection is selective, and periarterial divestment spares the artery in some cases. Short-term surgical morbidity does not appear to be increased by NAT, yet the absence of uniform protocols for post-reconstruction anticoagulation represents an important area for future investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>NAT has fundamentally transformed the management of BRPC, establishing a surgical pathway that is dictated by tumor biology and sequentially timed according to treatment response and clinical course. Optimizing outcomes ultimately depends on standardized restaging protocols, judicious selection of patients who truly benefit from resection, and the concentration of complex vascular procedures in high-volume, experienced centers. A practical algorithm is proposed to synthesize these decision points for clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsurg.2026.1935508","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:02:56Z","timestamp":1788897776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Surgical decision\u2013making in borderline resectable pancreatic cancer in the era of neoadjuvant therapy: from response assessment to individualized operative strategy"],"prefix":"10.3389","volume":"13","author":[{"given":"Lei","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of General Surgery, Panjin Liao-Oil Field Gem Flower Hospital","place":["PanJin, LiaoNing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Oncological Surgery, Panjin Liao-Oil Field Gem Flower Hospital","place":["PanJin, ,, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Panjin Liao-Oil Field Gem Flower Hospital","place":["PanJin, LiaoNing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Panjin Liao-Oil Field Gem Flower Hospital","place":["PanJin, LiaoNing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxin","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Quality Management, Panjin Liao-Oil Field Gem Flower Hospital","place":["PanJin, ,, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Thomas","year":"2025","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.3390\/cancers16162848","article-title":"Advancing pancreatic cancer surgical treatments and proposal of new approaches","volume":"16","author":"Cortiana","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1177\/00031348241248703","article-title":"The oncological stress test of neoadjuvant therapy: a systematic review in outcomes of neoadjuvant therapy compared to upfront resection approach for borderline resectable pancreatic adenocarcinoma","volume":"90","author":"Ross","year":"2024","journal-title":"Am Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.1245\/s10434-025-17736-5","article-title":"The landmark series: neoadjuvant therapy for resectable pancreatic cancer","volume":"32","author":"Chelsea","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41571-023-00746-1","article-title":"Neoadjuvant therapy for pancreatic cancer","volume":"20","author":"Springfeld","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B8","year":""},{"key":"B9","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1245\/s10434-009-0408-6","article-title":"Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement","volume":"16","author":"Callery","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.pan.2017.11.011","article-title":"International consensus on deffnition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017","volume":"18","author":"Isaji","year":"2018","journal-title":"Pancreatology"},{"key":"B11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Isaji","year":"2023","journal-title":"Ann Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"oyaf271","DOI":"10.1093\/oncolo\/oyaf271","article-title":"Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an academic gastrointestinal cancer consortium study","volume":"30","author":"Cohen","year":"2025","journal-title":"Oncologist"},{"key":"B13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4174\/astr.2025.109.3.162","article-title":"Statistical cure fraction in patients with borderline resectable pancreatic ductal adenocarcinoma undergoing neoadjuvant therapy followed by radical resection: a secondary analysis of reconstructed individual patient data","volume":"109","author":"Jang","year":"2025","journal-title":"Ann Surg Treat Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10147-023-02317-x","article-title":"Clinical practice guidelines for pancreatic cancer 2022 from the Japan pancreas society: a synopsis","volume":"28","author":"Okusaka","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jncc.2022.08.006","article-title":"Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of pancreatic cancer","volume":"2","author":"Cui","year":"2022","journal-title":"J Natl Cancer Cent"},{"key":"B16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/SLA.0000000000002705","article-title":"Oncological beneffts of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter phase 2\/3 trial","volume":"268","author":"Jang","year":"2018","journal-title":"Ann Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1200\/JCO.19.02274","article-title":"Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial","volume":"38","author":"Versteijne","year":"2020","journal-title":"J Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S2468-1253(22)00348-X","article-title":"Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial","volume":"8","author":"Ghaneh","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"zrae172","DOI":"10.1093\/bjsopen\/zrae172","article-title":"Neoadjuvant treatment versus upfront surgery in borderline resectable and resectable pancreatic ductal adenocarcinoma: meta-analysis","volume":"9","author":"Dickerson","year":"2025","journal-title":"BJS Open"},{"key":"B21","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/jhbp.12066","article-title":"Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy: a multicenter retrospective cohort study (PC-CURE-1)","volume":"31","author":"Okano","year":"2024","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.26355\/eurrev_202209_29656","article-title":"Efficacy and safety of neoadjuvant folfirinox and gemcitabine plus nab-paclitaxel for borderline resectable and locally advanced pancreatic cancer: a systematic review and meta-analysis","volume":"26","author":"Dong","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/SLA.0000000000005430","article-title":"Results of a phase II study on the use of neoadjuvant chemotherapy (FOLFIRINOX or GEM\/nab-PTX) for borderline-resectable pancreatic cancer (NUPAT-01)","volume":"275","author":"Yamaguchi","year":"2022","journal-title":"Ann Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12029-025-01287-9","article-title":"FOLFIRINOX vs. gemcitabine nab-paclitaxel in pancreatic cancer: a real-world single-center analysis of efficacy and safety","volume":"56","author":"Khan","year":"2025","journal-title":"J Gastrointest Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.amjsurg.2023.10.053","article-title":"Type of neoadjuvant treatment strategy is associated with differential pathologic responses in pancreatic ductal adenocarcinoma","volume":"232","author":"Akumuo","year":"2024","journal-title":"Am J Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006910","article-title":"Surgical complications in patients with (borderline) resectable pancreatic cancer after neoadjuvant therapy in the PREOPANC-2 randomized controlled trial","author":"Dekker","year":"2025","journal-title":"Ann Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1007\/s12094-024-03421-8","article-title":"Sarcopenia among treated cancer patients before and after neoadjuvant chemotherapy: a systematic review and meta-analysis of high-quality studies","volume":"26","author":"Su","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1245\/s10434-022-12985-0","article-title":"Change impact of body composition during neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma undergoing pancreatectomy","volume":"30","author":"Takaichi","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/jamasurg.2018.0979","article-title":"Association between changes in body composition and neoadjuvant treatment for pancreatic cancer","volume":"153","author":"Sandini","year":"2018","journal-title":"JAMA Surg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2214\/AJR.21.26931","article-title":"Imaging assessment of pancreatic cancer resectability after neoadjuvant therapy: AJR expert panel narrative review","volume":"218","author":"Soloff","year":"2022","journal-title":"AJR Am J Roentgenol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1007\/s00261-021-03284-5","article-title":"Can a simpliffed CT response criteria for vascular involvement in pancreatic adenocarcinoma after neoadjuvant therapy predict survival in patients who achieved subsequent R0 resection?","volume":"46","author":"Guo","year":"2021","journal-title":"Abdom Radiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1007\/s00330-020-07433-0","article-title":"CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis","volume":"31","author":"Park","year":"2021","journal-title":"Eur Radiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/JP9.0000000000000156","article-title":"Modern radiological assessment after neoadjuvant therapy in pancreatic cancer: an overview","volume":"7","author":"Steingr\u00fcber","year":"2024","journal-title":"J Pancreatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e52193","DOI":"10.7759\/cureus.52193","article-title":"Predicting pathological response to preoperative chemotherapy in pancreatic ductal adenocarcinoma using post-chemotherapy computed tomography radiomics","volume":"16","author":"Ikuta","year":"2024","journal-title":"Cureus"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1245\/s10434-023-14805-5","article-title":"Delta radiomic features predict resection margin Status and overall survival in neoadjuvant-treated pancreatic cancer patients","volume":"31","author":"Wang","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/JP9.0000000000000148","article-title":"Computed tomography-based delta radiomics of tumor core-edge combination for systemic treatment response evaluation in pancreatic cancer","volume":"7","author":"Li","year":"2024","journal-title":"J Pancreatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ijrobp.2022.09.084","article-title":"Predicting treatment response from extracellular volume fraction for chemoradiation therapy of pancreatic cancer","volume":"115","author":"Noid","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B38","doi-asserted-by":"publisher","first-page":"101669","DOI":"10.1016\/j.adro.2024.101669","article-title":"Delta-radiomics approach using contrast-enhanced and noncontrast-enhanced computed tomography images for predicting distant metastasis in patients with borderline resectable pancreatic carcinoma","volume":"10","author":"Adachi","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1007\/s00330-023-10381-0","article-title":"Diffusion-weighted imaging for determining response to neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis","volume":"34","author":"Bilreiro","year":"2024","journal-title":"Eur Radiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"111893","DOI":"10.1016\/j.ejrad.2024.111893","article-title":"Multiparametric quantitative diffusion weighted magnetic resonance imaging can effectively predict the response to neoadjuvant therapy in borderline resectable pancreatic ductal adenocarcinoma","volume":"183","author":"Qu","year":"2025","journal-title":"Eur J Radiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1186\/s12885-024-12934-y","article-title":"Values of apparent diffusion coefffcient in pancreatic cancer patients receiving neoadjuvant therapy","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.6004\/jnccn.2022.7041","article-title":"FDG-PET predicts neoadjuvant therapy response and survival in borderline resectable\/locally advanced pancreatic adenocarcinoma","volume":"20","author":"Abdelrahman","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"key":"B43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40644-023-00565-8","article-title":"Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, 18F-FDG PET\/MRI and CA 19-9","volume":"23","author":"Yoo","year":"2023","journal-title":"Cancer Imaging"},{"key":"B44","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/jnci\/djae294","article-title":"Prognostic factors in localized pancreatic ductal adenocarcinoma after neoadjuvant therapy and resection: a systematic review and meta-analysis","volume":"117","author":"Javed","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"B45","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.pan.2025.06.016","article-title":"Prognostic impact of post-neoadjuvant CA19-9 values in pancreatic cancer: more pronounced following neoadjuvant chemotherapy compared to neoadjuvant chemoradiotherapy","volume":"25","author":"Miyahara","year":"2025","journal-title":"Pancreatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e2400193","DOI":"10.1200\/PO.24.00193","article-title":"Development of a composite score based on carbohydrate antigen 19-9 dynamics to predict survival in carbohydrate antigen 19-9-producing patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment","volume":"8","author":"Rompen","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"8906","DOI":"10.1245\/s10434-025-18084-0","article-title":"Favorable response deffned by CA19-9 reduction after neoadjuvant treatment for pancreatic cancer","volume":"35","author":"Ashitomi","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.surg.2024.06.049","article-title":"A striking elevation of CA19-9 after preoperative therapy negates prognostic benefft from radical surgery in resectable and borderline resectable pancreatic cancer","volume":"176","author":"Akita","year":"2024","journal-title":"Surgery"},{"key":"B49","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/SLA.0000000000001741","article-title":"Potential biomarkers in lewis negative patients with pancreatic cancer","volume":"265","author":"Luo","year":"2017","journal-title":"Ann Surg"},{"key":"B50","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pan.2020.12.017","article-title":"Molecular proffling of ctDNA in pancreatic cancer: opportunities and challenges for clinical application","volume":"21","author":"Sivapalan","year":"2021","journal-title":"Pancreatology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1245\/s10434-023-14751-2","article-title":"Initial report: personalized circulating tumor DNA and survival in patients with resectable pancreatic cancer","volume":"31","author":"Eckhoff","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/SLA.0000000000006562","article-title":"Mutant KRAS in circulating tumor DNA as a biomarker in localized pancreatic cancer in patients treated with neoadjuvant chemotherapy","volume":"284","author":"Vitello","year":"2026","journal-title":"Ann Surg"},{"key":"B53","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1245\/s10434-025-17433-3","article-title":"Elevated carcinoembryonic antigen levels predict failure to reach surgery in patients with borderline resectable pancreatic cancer referred to neoadjuvant therapy","volume":"32","author":"Jacover","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/XCS.0000000000000704","article-title":"Yield of staging laparoscopy for pancreatic cancer in the modern era: analysis of more than 1,000 consecutive patients","volume":"237","author":"Gudmundsdottir","year":"2023","journal-title":"J Am Coll Surg"},{"key":"B55","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ejso.2022.12.011","article-title":"The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the PREOPANC randomized controlled trial","volume":"49","author":"van Dongen","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.pan.2022.03.017","article-title":"The clinical benefits of performing staging laparoscopy for pancreatic cancer treatment","volume":"22","author":"Imamura","year":"2022","journal-title":"Pancreatology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1245\/s10434-025-17036-y","article-title":"Molecular KRAS ctDNA predicts metastases and survival in pancreatic cancer: a prospective cohort study","volume":"32","author":"Leiting","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/cancers15030652","article-title":"Consensus statement on the use of near-infrared fluorescence imaging during pancreatic cancer surgery based on a delphi study: surgeons\u2019 perspectives on current use and future recommendations","volume":"15","author":"de Muynck","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/SLA.0000000000005874","article-title":"The revised R status is an independent predictor of postresection survival in pancreatic cancer after neoadjuvant treatment","volume":"279","author":"Leonhardt","year":"2024","journal-title":"Ann Surg"},{"key":"B60","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.surg.2014.02.001","article-title":"Borderline resectable pancreatic cancer: a consensus statement by the international study group of pancreatic surgery (ISGPS)","volume":"155","author":"Bockhorn","year":"2014","journal-title":"Surgery"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.ejso.2023.03.229","article-title":"Pancreatectomy with venous vascular resection for pancreatic cancer: impact of types of vein resection on timing and pattern of recurrence","volume":"49","author":"Tamburrino","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"7150","DOI":"10.1097\/JS9.0000000000002034","article-title":"Clinical outcomes of preservation versus resection of portal\/superior mesenteric vein during pancreaticoduodenectomy in pancreatic cancer patients who respond to neoadjuvant treatment: a retrospective cohort study","volume":"110","author":"Chae","year":"2024","journal-title":"Int J Surg"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.surg.2020.07.054","article-title":"Mesoportal bypass, interposition graft, and mesocaval shunt: surgical strategies to overcome superior mesenteric vein involvement in pancreatic cancer","volume":"168","author":"Kinny-K\u00f6ster","year":"2020","journal-title":"Surgery"},{"key":"B64","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jviscsurg.2024.04.003","article-title":"Mesenteric and portal venous resections during pancreatoduodenectomy","volume":"161","author":"Da Silva","year":"2024","journal-title":"J Visc Surg"},{"key":"B65","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.surg.2020.04.033","article-title":"The left splenorenal venous shunt decreases clinical signs of sinistral portal hypertension associated with splenic vein ligation during pancreaticoduodenectomy with venous resection","volume":"168","author":"Addeo","year":"2020","journal-title":"Surgery"},{"key":"B66","doi-asserted-by":"publisher","first-page":"101540","DOI":"10.1016\/j.jvscit.2024.101540","article-title":"Temporary mesenteric venous shunting for portal vein reconstruction: a novel technical adjunct","volume":"10","author":"Quatromoni","year":"2024","journal-title":"J Vasc Surg Cases Innov Tech"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.3390\/cancers16132361","article-title":"Use of vascular shunt at the time of pancreatectomy with venous resection: a systematic review","volume":"16","author":"Libia","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006662","article-title":"Temporary portal vein bypass for resection of pancreatic neoplasms","author":"Heckler","year":"2025","journal-title":"Ann Surg"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s00423-021-02382-8","article-title":"The short-term outcomes of distal pancreatectomy with portal vein\/superior mesenteric vein resection","volume":"407","author":"Xu","year":"2022","journal-title":"Langenbecks Arch Surg"},{"key":"B70","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00423-025-03826-1","article-title":"How-I-Do-It: meso-caval shunt: a safe emergency option for venous reconstruction in pancreaticoduodenectomy","volume":"410","author":"Wei","year":"2025","journal-title":"Langenbecks Arch Surg"},{"key":"B71","doi-asserted-by":"publisher","first-page":"rjaf624","DOI":"10.1093\/jscr\/rjaf624","article-title":"Pancreatectomy with en bloc superior mesenteric vein resection and permanent mesocaval shunting for locally advanced pancreatic head cancer","volume":"2025","author":"Fujii","year":"2025","journal-title":"J Surg Case Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00423-024-03446-1","article-title":"Pancreatoduodenectomy with superior mesenteric vein resection and non-reconstruction for pancreatic head cancer paying particular attention to hemodynamics","volume":"409","author":"Sugitani","year":"2024","journal-title":"Langenbecks Arch Surg"},{"key":"B73","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/SLA.0000000000006248","article-title":"REDISCOVER international guidelines on the perioperative care of surgical patients with borderline-resectable and locally advanced pancreatic cancer","volume":"280","author":"Boggi","year":"2024","journal-title":"Ann Surg"},{"key":"B74","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/bjs\/znac353","article-title":"Pancreatectomy with arterial resection for periampullary cancer: outcomes after planned or unplanned events in a nationwide, multicentre cohort","volume":"110","author":"Stoop","year":"2023","journal-title":"Br J Surg"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.surg.2020.11.030","article-title":"Not all whipple procedures are equal: proposal for a classiffcation of pancreatoduodenectomies","volume":"169","author":"Mihaljevic","year":"2021","journal-title":"Surgery"},{"key":"B76","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jamcollsurg.2018.05.001","article-title":"Indications and perioperative outcomes for pancreatectomy with arterial resection","volume":"227","author":"Tee","year":"2018","journal-title":"J Am Coll Surg"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/cancers17091540","article-title":"Arterial resections in pancreatic cancer-an updated systematic review and meta-analysis","volume":"17","author":"Noel","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B78","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/SLA.0000000000004054","article-title":"Arterial resection in pancreatic cancer surgery: effective after a learning curve","volume":"275","author":"Loos","year":"2022","journal-title":"Ann Surg"},{"key":"B79","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.1097\/JS9.0000000000000971","article-title":"Postoperative results, learning curve, and outcomes of pancreatectomy with arterial resection: a single-center retrospective cohort study on 236 procedures","volume":"110","author":"Napoli","year":"2024","journal-title":"Int J Surg"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.surg.2020.08.030","article-title":"Periarterial divestment in pancreatic cancer surgery","volume":"169","author":"Diener","year":"2021","journal-title":"Surgery"},{"key":"B81","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.sopen.2023.03.001","article-title":"Technical options in surgery for artery-involving pancreatic cancer: invasion depth matters","volume":"12","author":"Miao","year":"2023","journal-title":"Surg Open Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00423-021-02080-5","article-title":"Sub-adventitial divestment technique for resecting artery-involved pancreatic cancer: a retrospective cohort study","volume":"406","author":"Cai","year":"2021","journal-title":"Langenbecks Arch Surg"},{"key":"B83","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/diagnostics16010102","article-title":"Diagnosis and surgical management for advanced pancreatic cancer requiring vascular resection","volume":"16","author":"Symeou","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"B84","doi-asserted-by":"publisher","first-page":"109412","DOI":"10.1016\/j.surg.2025.109412","article-title":"Periarterial divestment for borderline and locally advanced pancreatic cancer: an analysis of 125 cases in a single center","volume":"184","author":"Yang","year":"2025","journal-title":"Surgery"},{"key":"B85","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/jamasurg.2020.5676","article-title":"Contemporary reappraisal of intraoperative neck margin assessment during pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a review","volume":"156","author":"Datta","year":"2021","journal-title":"JAMA Surg"},{"key":"B86","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pan.2024.12.008","article-title":"Frozen section analysis of pancreatic resection margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is not affected by neoadjuvant therapy","volume":"25","author":"Otero","year":"2025","journal-title":"Pancreatology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1097\/SLA.0000000000003503","article-title":"Revision of pancreatic neck margins based on intraoperative frozen section analysis is associated with improved survival in patients undergoing pancreatectomy for ductal adenocarcinoma","volume":"274","author":"Zhang","year":"2021","journal-title":"Ann Surg"},{"key":"B88","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.1245\/s10434-020-09568-2","article-title":"What should guide the performance of venous resection during pancreaticoduodenectomy for pancreatic ductal adenocarcinoma with venous contact?","volume":"28","author":"Navez","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/PAS.0000000000002013","article-title":"Integrated pathologic score effectively stratifies patients with pancreatic ductal adenocarcinoma who received neoadjuvant therapy and pancreaticoduodenectomy","volume":"47","author":"Sohn","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"6004","DOI":"10.1245\/s10434-022-11804-w","article-title":"Intraoperative pancreatic neck margin assessment during pancreaticoduodenectomy for pancreatic adenocarcinoma in the era of neoadjuvant therapy: a multi-institutional analysis from the central pancreatic consortium","volume":"29","author":"Kelly","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.amjsurg.2013.01.015","article-title":"Examining the accuracy and clinical usefulness of intraoperative frozen section analysis in the management of pancreatic lesions","volume":"205","author":"Nelson","year":"2013","journal-title":"Am J Surg"},{"key":"B92","first-page":"847","article-title":"Interobserver variability and challenges in intraoperative frozen section evaluation of pancreatic margins in pancreatectomy specimens","volume":"53","author":"Dhingra","year":"2023","journal-title":"Ann Clin Lab Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.5858\/arpa.2023-0359-RA","article-title":"Intraoperative frozen section evaluation of pancreatic specimens and related liver lesions","volume":"149","author":"Vazzano","year":"2025","journal-title":"Arch Pathol Lab Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1245\/s10434-020-09460-z","article-title":"Neoadjuvant therapy for pancreatic ductal adenocarcinoma: propensity-matched analysis of postoperative complications using ACS-NSQIP","volume":"28","author":"Krell","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1177\/00031348221087900","article-title":"Comparing post-operative outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: neoadjuvant therapy versus surgery first approach","volume":"88","author":"Hyman","year":"2022","journal-title":"Am Surg"},{"key":"B96","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/XCS.0000000000000971","article-title":"Impact of neoadjuvant therapy for pancreatic cancer: transatlantic trend and postoperative outcomes analysis","volume":"238","author":"Davis","year":"2024","journal-title":"J Am Coll Surg"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.surg.2024.01.029","article-title":"Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic Fistula after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a nationwide analysis","volume":"175","author":"Wismans","year":"2024","journal-title":"Surgery"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.hpb.2021.04.027","article-title":"The effect of preoperative chemotherapy and chemoradiotherapy on pancreatic Fistula and other surgical complications after pancreatic resection: a systematic review and meta-analysis of comparative studies","volume":"23","author":"Van Dongen","year":"2021","journal-title":"HPB (Oxford)"},{"key":"B99","doi-asserted-by":"publisher","first-page":"109552","DOI":"10.1016\/j.surg.2025.109552","article-title":"Impact of neoadjuvant therapy on short-term outcomes after left pancreatectomy: a propensity score-matched international multicenter study","volume":"185","author":"Bonsdorff","year":"2025","journal-title":"Surgery"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1111\/ans.15885","article-title":"Impact of neoadjuvant therapy on PostOperative pancreatic Fistula: a systematic review and meta-analysis","volume":"90","author":"Kamarajah","year":"2020","journal-title":"ANZ J Surg"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1245\/s10434-023-14763-y","article-title":"Neoadjuvant chemotherapy is associated with increased risk of postoperative DVT after distal pancreatectomy for pancreatic adenocarcinoma: a NSQIP analysis","volume":"31","author":"Robbins","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO clinical practice guideline","volume":"34","author":"Falanga","year":"2023","journal-title":"Ann Oncol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.23.0029","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.hpb.2021.12.010","article-title":"AHPBA guidelines for managing VTE prophylaxis and anticoagulation for pancreatic surgery","volume":"24","author":"Clancy","year":"2022","journal-title":"HPB (Oxford)"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1007\/s00268-020-05462-w","article-title":"Guidelines for perioperative care for pancreatoduodenectomy: enhanced recovery after surgery (ERAS) recommendations 2019","volume":"44","author":"Melloul","year":"2020","journal-title":"World J Surg"},{"key":"B107","doi-asserted-by":"publisher","first-page":"423","DOI":"10.14701\/ahbps.23-065","article-title":"Anticoagulation after pancreatic surgery with venous resection (TIGRESS): what should we do? Results from an international survey","volume":"27","author":"Russell","year":"2023","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"B108","doi-asserted-by":"publisher","first-page":"101852","DOI":"10.1016\/j.gassur.2024.10.007","article-title":"Thrombosis and anticoagulation after portal vein reconstruction during pancreatic surgery: a systematic review","volume":"29","author":"Heckler","year":"2025","journal-title":"J Gastrointest Surg"},{"key":"B109","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1097\/JS9.0000000000001755","article-title":"Comparison of patency rates and complications with or without antithrombotic therapy following portal vein stent placement after pancreatic surgery: a systematic review and meta-analysis","volume":"110","author":"Chen","year":"2024","journal-title":"Int J Surg"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006954","article-title":"Anticoagulation practice and risk of portal vein thrombosis following pancreaticoduodenectomy or total pancreatectomy with venous resection: an international multicentre cohort study","author":"Labib","year":"2025","journal-title":"Ann Surg"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.hpb.2022.06.005","article-title":"Patency rates of hepatic arterial resection and revascularization in locally advanced pancreatic cancer","volume":"24","author":"Alva-Ruiz","year":"2022","journal-title":"HPB (Oxford)"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1935508\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:02:58Z","timestamp":1788897778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1935508\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":111,"alternative-id":["10.3389\/fsurg.2026.1935508"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2026.1935508","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"article-number":"1935508"}}